Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by SPCEO1on Apr 19, 2021 1:02pm
151 Views
Post# 33022504

RE:RE:RE:Wino, have you attempted or succeeded in reaching out

RE:RE:RE:Wino, have you attempted or succeeded in reaching outI would contact him as realitycheck4u has suggested. I am assuming that Paul will know all about our discussions here before he sits down to speak with you. Obviously, Dawn should be on the call as well and I am suer she will be fully briefed. There is no hidden agenda here, at least on our side of the equation. You know the issues, you know the markets and I am sure that, at a minimum, you can offer some helpful wisdom for them about how to go about fixing this mess. Both Dawn and Paul appear to me to be tough but fair people. After the initial uncomfortable period that is inevitable in such situations, I think you three will quickly end up having a conversation that will be useful. It may get contentious from time to time but Dawn and Paul are serious people so I would not expect a total meltdown to occur. Be yourself, becasue that is pretty impressive. They are really good but you are really good too, so you should all be on equal footing and all of you actually all share the same goal. So, be prepared to be challengend and to challenge right back.

Hopefully, you can start out by identifying the main issues that need to be addressed and not get sidetracked from those. 

realitycheck4u wrote: Well, send an email directly to him. "Long time poster, first time caller...I am known as Wino. Care to have a virtual drink with me". 

Direct that to Paul. I'm sure you can find his email address.

Wino115 wrote: Not yet -- have things on my plate today and want to formulate my approach.  Suggestions welcomed!  Any thoughts?

realitycheck4u wrote: Just wondering.

 




<< Previous
Bullboard Posts
Next >>